The market under-reacted to their results IMO. The market needs to raise the odds of higher earnings in the future now, and sucked its thumb for a while. IMO it will be worth $1.20 ish arguably, if the success is built upon from here, and then you need to apply the odds of success/failure to reduce the value from that, say 50%, probability outcome. It was no longer worth under 40c any more IMO.
- Forums
- ASX - By Stock
- KME
- Ann: Appendix 4E and 30 June 2017 Annual Report
Ann: Appendix 4E and 30 June 2017 Annual Report, page-33
Featured News
Add KME (ASX) to my watchlist
(20min delay)
|
|||||
Last
47.5¢ |
Change
0.020(4.40%) |
Mkt cap ! $27.00M |
Open | High | Low | Value | Volume |
46.0¢ | 47.5¢ | 46.0¢ | $12.08K | 26.05K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13356 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.5¢ | 17160 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 439 | 0.915 |
1 | 7582 | 0.910 |
1 | 5524 | 0.905 |
2 | 20484 | 0.900 |
1 | 1149 | 0.870 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 557 | 1 |
0.950 | 12474 | 2 |
0.960 | 53883 | 2 |
0.970 | 20668 | 1 |
0.980 | 27357 | 2 |
Last trade - 11.09am 25/11/2024 (20 minute delay) ? |
Featured News
KME (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online